With downgrade, HSBC casts doubt about Lilly's 'stairway to heaven' trajectory
18th March 2026 Uncategorised 0Since investment bank HSBC downgraded the stock of Eli Lilly from “hold” to “reduce” on Tuesday morning, the share price of the Indianapolis drugmaker has dropped by more than 7%. Creating the stir was a note from analyst Rajesh Kumar, which cited pricing pressures and increased competition in the obesity market.
More: With downgrade, HSBC casts doubt about Lilly's 'stairway to heaven' trajectory
Source: fierce